News
Summit Therapeutics (SMMT) stock gains as AstraZeneca (AZN) is said to eye its lung cancer drug ivonescimab, a potential ...
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, ...
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
3d
Zacks Investment Research on MSNWall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to TradeShares of Summit Therapeutics PLC (SMMT) have gained 2.8% over the past four weeks to close the last trading session at $21.2 ...
Tesla's new car sales in Britain rose year-on-year in June amid a broader recovery in the electric-vehicle market, data ...
5d
GlobalData on MSNUK vehicle production constraints affect May output: SMMTUK vehicle production continues to face constraints, with figures from the Society of Motor Manufacturers and Traders (SMMT) ...
Shares of Summit Therapeutics jumped 9% Thursday on a report that it was discussing a lucrative partnership deal with AstraZeneca.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results